Adicet Bio, Inc. (ACET) stock

ACETNasdaqPharmaceutical PreparationsFiscal year ends December 26

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30

$2.93−0.06 (-2.01%)

Close on Nov 12, 2026Market cap $27.43MP/E –Yield –

Adicet Bio gross margin

Gross margin is gross profit as a percentage of revenue.

Adicet Bio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?